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Abstract
Chronic non-cancer pain is a complex health condition that affects more than a quarter
of the Italian population who mainly refers to general practitioners and primary care
for their treatment. There are little information on the epidemiological and clinical
characteristics and types of treatments for these patients who suffer from chronic pain.
The aim of the study was to provide epidemiological and clinical information about
patients with chronic non-cancer pain who refers to GPs for their treatment. An
observational, multicentre, cross-sectional study was carried out using retrospectively
reviewed clinical records from 29 GPs. Some pharmacoeconomic aspects were also
investigated. A total of 1,007 patients who had chronic pain were selected for the study.
Chronic pain was more common in women than in men (ratio 2.7 : 1) (P = 0.002).
With regard to incomes, the women earned less than the men (P = 0.017). The chronic
pain was musculoskeletal (73.4%), mixed (21.4%), neuropathic (4.9%) and visceral
(0.3%). More women than men had pain in two or more sites, and 33.5% of the patients
reported more than one diagnosis that related to chronic pain. The general practitioners
had prescribed nonsteroidal anti-inflammatory drugs for 71.8% of the cases, opioids for
16.9%, adjuvants for 9.0% and acetaminophen for 2.4%, and about pharmacoeconomic
aspects, the total cost for the sample was € 111,331.42. Primary care is the essential
frontline for patients who suffer from non-cancer pain. An interdisciplinary assessment
and approach should start in primary care delivery to maximize the clinical outcomes.
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1. Introduction
Chronic non-cancer pain (CP) is generally recognized as a
major public health problem and is one of the most common
reasons why patients seek medical care [1]. Chronic pain can
have devastating impact on well-being, daily activities [2–4],
with clinical, social and economic burdens [5, 6]. Indeed, the
costs of chronic pain are expected to increase to an estimated
$10.29 billion per year by 2025 [7], without do not include
societal costs [8]. Chronic pain should be looked at as a chronic
condition in itself; a disease in its own right [9]. A recent
review of studies reported that the prevalence of chronic pain
in the general adult populations worldwide ranged from 8% to
30% [10], and in Italy, chronic pain affects about 28% of the
population [11].
Primary care physicians are at the forefront of chronic pain
management. The prevalence of chronic pain in primary care
increases with age [12, 13] and is found more often in patients
who are older than 60 years [14]. According to previous
studies, the prevalence of chronic pain in elderly populations
varies considerably, ranging from 27% to 86% [15]. Chronic
pain is prevalent among widows, people who are divorced and
those who are unemployed but appears to be inversely related
to education [16]. This type of pain is more common among
women than men [11, 12, 17], with women experiencing pain
in more sites and with greater intensities [18, 19], and is mainly
musculoskeletal rather than of a neuropathic or mixed nature
[19]. Chronic pain has an average duration of 7.6 years [16]
and mainly involves the back and lower back, neck, limbs,
and joints [20]. Patients who have chronic pain also visit their
GPs twice as often as patients who do not [21]. Consultations
on pain account for 22% of all primary care consultations
[22]. GPs should perform initial holistic assessments that
include the severity, impacts and types of pain that patients
are experiencing [23]. In addition, programs are likely to be
optimized when implemented in the context of continuity of
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FIGURE 1. Costs of treatments between age and sex.
care [24, 25].
GPs could offer treatments and better approaches for
patients with chronic pain, using pharmacological and
non-pharmacological interventions implemented through a
network of services [26, 27]. Initial treatment is recommended
with non steroidal anti-inflammatory drugs (NSAID),
adjuvants and opioids. However, the high prevalence of
comorbidity in patients with chronic pain may limit the
applicability and usefulness of clinical guidelines [28], and for
this reason GPs and nurses can support non-pharmacological
treatments as complementary or integrative therapies that
are commonly used along with pain control regimens [29].
Whatever interventions are prescribed, it is important for
GPs to evaluate and re-evaluate these at all phases of the
chronic pain management [30]. An overall reduction in the
intensity of pain, by 30% to 50%, is formally considered to
be a successful outcome, as is an overall improvement in
quality of life [31]. The successful management of chronic
pain in primary care relies on multidisciplinary and holistic
approaches aimed at both minimizing pain as much as possible
and teaching patients how to live well with chronic pain [32].
In Italy, management for chronic pain is described in hospitals
[22, 33, 34] and pain clinics [4, 19, 35]; however, this does
not necessarily reflect what happens among patients who rely
on their GPs to treat their pain. It can be said, then, that the
epidemiology and treatment of chronic pain in the general
population is almost unknown [26].
Therefore, the goal of this study is to describe the manage-
ment of chronic pain among primary care settings in Italy.
2. Material and methods
2.1 Study design
A retrospective chart review was conducted. Patients who
attended primary care centres in the Latium region at least once
in 2011 (either as a first visit or subsequent visits) were the
target population. The data were collected between December
2012 and January 2014. This research report was written
according to the Strengthening the Reporting of Observational
Studies in Epidemiology Recommendations [36].
2.2 Sample
The study included records of patients, whowere selected from
the 29GPs belonging to the Italian Society of GeneralMedicine
(SIMMG), which is connected to the project management of
data. A consecutive series of patients satisfying inclusion
criteria with variable sampling fractions from each of the
29 GPs yielded a sample of clinical records that the GPs
had completed. Information was extracted using a structured
template to standardize the clinical information that the GPs
had collected and used.
2.3 Definition of ''chronic non-cancer pain
case''
Although chronic non-cancer pain as been defined as pain that
persists or recurs for more than three months [9], we used
the standard definition of the International Association for the
Study of Pain (IASP) that defines chronic pain as an unpleasant
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sensory and emotional experience with a duration of over six
months [37]. However, in the 2014 International Classification
of Diseases (ICD), chronic pain diagnoses were not published.
2.4 Inclusion and exclusion criteria
The inclusion criteria were male and female adults aged over
18 years who had attended primary care in the Latium region
from January 1, 2011, to December 31, 2011, and whose
medical records reported either diagnoses of chronic pain or
that they had consumed a number of packs of analgesics in
the fourth quartile of consumption of painkillers (over three
packs). Patients who had accessed primary care during the
study period and had not yet received diagnoses of chronic pain
but were suffering pain were also included. Only patients with
pain that was not caused by cancer were included. Patients
with migraines, headaches and pain resulting from cancer were
excluded. Patients with incomplete or unclear medical records
were also excluded.
2.5 Data collection
Data from the primary care centres were collected by two
members of the research team (A.C. and A.R.). When demo-
graphic variables were available, they were extracted from the
records using the database software forWindows (Win-world).
The following variables were collected: patient identification
codes; demographic variables including age and sex; clinical
variables such as the ICD-9 codes; the nature of the pain (mus-
culoskeletal, neuropathic, mixed and visceral) [9]; the sites
and numbers of the locations of pain; the allopathic treatment
including NSAIDs, opioids, adjuvants and acetaminophen;
about pharmacoeconomic aspects, the average costs of the
treatments and the incomes are described.
2.6 Statistical analysis
The mean with its relative standard deviation (SD) and median
values for were used for summarized quantitative variables,
while absolute and relative frequencies were used for qual-
itative variables. Associations between qualitative variables
were assessed through Pearson’s Chi-square tests. Univariate
and multivariate analyses were carried out to investigate which
variables were associated with chronic pain, considering the
different nature of the pain (neuropathic and mixed pain vs
musculoskeletal) as the dependent variable. Odds ratios (OR)
and their relative 95% Confidence intervals (95% CI) were
calculated for all the demographic and clinical characteristics
of the patients. Statistical significance was set at a value of P
< 0.05, using SPSS Version 22.0 (IBM Corp., Armonk, NY,
USA) software.
2.7 Ethics committee
The study was reviewed and approved by the research
group’s internal review board, which was the relevant
cross-institutional committee responsible for assessing the
methodological appropriateness and ethicality of the study
design. The study was approved by the Ethical Committee
(prot. 456/12). Data of treatment observed fundamental rights
and liberties (article 13 Italian Law 196/2003; guidelines
for data processing Ministerial Decree July 5, 1997, and
Law Decree 200/2007) and the Helsinki Declaration (Ethical
Guidelines for Observational Studies). The research involved
anonymised records and data sets that exist in the public
domain, where appropriate permissions have already been
obtained, and it is not possible to identify individuals from the
information provided.
3. Results
3.1 Age distribution and income
The study examined 1,007 patients affected by chronic non-
cancer pain. Of these patients, 73.0% (735) were women,
and 27.0% (272) were men. The sample had a mean age of
69.2 years (SD ± 13.9), from 27 to 97 years; 51.5% (519)
of the sample was 70 years of age or over, and only 4.0%
of the patients were less than 40 years old. Almost 50% of
the sample had suffered from chronic pain for over four years
(Table 1). Chronic pain was more common among women
than men (ratio 2.7 : 1), and the difference was statistically
significant (P = 0.002). With regard to incomes, 16.9% (170)
of the patients earned € 36,151.98 a year or less. The results
indicate that the women earned less than the men (ꭓ2 = 35.730,
df = 20; P = 0.017).
3.2 Sites of pain
The results showed that the women experienced pain in more
sites than the men: 34.6% of the women complained of chronic
pain in two or more sites, whereas in men this was 30.5% (ꭓ2
= 6.759, df = 2; P = 0.034). The number of sites increased
with age, but this was not statistically significant (ꭓ2 = 8.212,
df = 12; P = 0.768, data not shown). Table 2 describes the
differences between the sexes in terms of the locations of the
body (ꭓ2 = 304.0, df = 288; P = 0.248).
3.3 Nature, classification, and clinical
diagnosis of pain
The chronic pain was mostly musculoskeletal (73.4%), fol-
lowed by mixed (21.4%), neuropathic (4.9%) and visceral
(0.3%). The nature of the pain was not statistically signif-
icantly different between men and women (ꭓ2 = 9.825, df
= 5; P = 0.081), as shown in Table 1, or between the age
groups (data not shown). Table 3 reports the clinical diagnoses
described in the medical databases of each GP according to
the ICD-9. For the majority of patients, chronic pain was
caused by musculoskeletal conditions such as osteoarthritis,
sciatica, low back pain and displacement of intervertebral
discs. Neuropathic pain was reported mainly in cases of herpes
zoster, polyneuropathy and trigeminal neuralgia, and visceral
pain was very seldom reported. More than half of the patients
(66.5%) reported chronic pain as a result of a single diagnosis
based on the ICD-9 code.
3.4 Risk factors for chronic pain
Table 4 describes the results of the univariate and multivariate
logistic regression model. Chronic neuropathic pain was more
common in patients who were over 70 years of age (P = 0.004),
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TABLE 1. Distribution of age and sex.
Variables Male (N = 272) Female (N = 735) Total (N = 1,007) P-value
n % n % n %
Age
< 40 12 4.4 28 3.8 40 4.0 0.002
40-49 23 8.5 56 7.6 79 7.8
50-54 17 6.3 24 3.3 41 4.1
55-59 15 5.5 53 7.2 68 6.8
60-64 41 15.1 84 11.4 125 12.4
65-69 50 18.4 85 11.6 135 13.4
≥ 70 114 41.9 405 55.1 519 51.5
NumberSites
1 166 51.8 417 67.6 583 69.3 0.034
2 55 24.6 170 27.6 225 26.8
3 3 1.3 30 4.9 33 3.9
Duration
< 48 months 149 54.8 369 50.2 518 51.4 0.322
48 + months 123 45.2 366 49.8 489 48.6
Nature of Chronic Pain
Muscoloskeletal 191 70.2 548 74.6 739 73.4 0.081
Visceral 0 0 3 0.4 3 0.3
Neuropathic 18 6.6 31 4.2 49 4.9
Mixed 63 23.2 153 20.8 216 21.4
along with greater numbers of sites on the locations in their
bodies (P < 0.001), and was treated with NSAIDs and opioids
(P < 0.001) and also, in particular, with adjuvants P < 0.001).
3.5 Analgesic treatments
The study examined 2,213 prescriptions for 52 molecule treat-
ments (data not shown). The different treatments used by the
patients for chronic pain include NSAIDs, opioids (weak and
strong), adjuvants and acetaminophen. There is an increasing
trend to prescribe adjuvant medications for female patients
to improve pain management (ꭓ2 = 9.33, df =1; P = 0.005),
and this is shown in Table 1. The GPs had prescribed the
following: NSAIDs for 71.8% (1,589), opioids for 16.9%
(373), adjuvants for 9.0% (199) and acetaminophen for 2.4%
(52). The distribution of pharmacological classes indicates
differences between the sexes: male use was 70.1% NSAIDs
(399), while use of these among woman was 72.3% (1,190).
Opioids use was 15.1% in men (86) and 17.5% in women
(287). Adjuvant use by men was 12.3% (70) and 7.9% in
women (129). The use of acetaminophen in men was 2.5%
(14) and 2.3% (38) in women. In general, women used more
pharmacological treatments than men (p < 0.001). Moreover,
the use of weak and strong opioids was 29.8% (300). Of these
69% (207) for musculoskeletal chronic pain, and 31% (93) for
neuropathic chronic pain.
3.6 Pharmacoeconomic aspects
The total cost for 1,007 patients suffering from chronic non-
cancer pain was € 111,331.42, while the cost for each patient
was € 110.56. The highest expenditure was recorded in the
65 to 69-year-old age group (Figure 1). In patients aged from
60 to 64 years, the highest expenditures were most frequently
recorded for men rather than women. After these ages, the
costs for women were higher than for men, and the difference
is statistically significant (ꭓ2 = 35.13; df = 1; P ≤ 0.001).
4. Discussion
To the best of our knowledge, this study was the first in Italy
to investigate the clinical characteristics of patients who went
to GPs for the management of chronic non-cancer pain. This
retrospective study sheds light on the management of chronic
pain after the enactment of the Italian Law 38/2010 and the
creation of the Network for the Diagnosis and Treatment of
Non-cancer Chronic Pain between primary care and pain clin-
ics. Primary care physicians are at the forefront of chronic pain
management. This study shows that general populations seek
consultations with their GPs for the management of chronic
pain. Patients who have such pain visit their GPs twice as
often as patients who do not [21], and patients were referred
to pain clinics by their GP are about 40% [19]. In accordance
with other studies, ours found that women are more likely than
men to use primary care for the treatment of chronic pain, to
use pharmacological treatments for pain, and to experience
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TABLE 2. Body locations of pain according to sex body.
Body Locations Male (N = 285) Female (N = 851) Total (N = 1,136)
n % n % n %
Lumbo-sacral 49 17.2 128 15.0 177 15.6
Lumbar, unspecified 52 18.2 114 13.4 166 14.6
Widespreadpain 29 10.2 116 13.6 145 12.8
Knee 23 8.1 107 12.6 130 11.4
Upper back 17 6.0 71 8.3 88 7.7
Neck 28 9.8 60 7.1 88 7.7
Shoulder 17 6.0 62 7.3 79 7.0
Legs 15 5.3 56 6.6 71 6.3
Hip 19 6.7 41 4.8 60 5.3
Feet 10 3.5 23 2.7 33 2.9
Hand 9 3.2 22 2.6 31 2.7
Chest 4 1.4 13 1.5 17 1.5
Arms 4 1.4 13 1.5 17 1.5
Face 4 1.4 9 1.1 13 1.1
Abdomen 1 0.4 7 0.8 8 0.7
Pelvis 1 0.4 5 0.6 6 0.5
Calf 1 0.4 2 0.2 3 0.3
Head 1 0.4 1 0.1 2 0.2
Joint, unspecifi 1 0.4 0 0 1 0.1
Stomach 0 0 1 0.1 1 0.1
Total 285 851 1136
∗ Percentages do not add up to 100% because categories are not mutually exclusive.
pain at many more sites [19, 38]. There is strong evidence
that differences between the sexes in relation to pain and
its relief arise from an interaction of genetic, physiological,
neuronal, hormonal and psycho-social factors that modulate
pain differently [39]. Furthermore, pain has a significant
association with increased age, as other studies have also
reported [12, 40]. These studies, along with ours, demonstrate
increases in the prevalence of chronic pain to the ages of about
40 to 50 and then either a continuation of increasing prevalence
or a plateauing of the prevalence in older age groups. Only 4%
of those in our sample who were less than 40 years of age used
GPs for pain management. It is possible that young people
self-medicate more frequently. However, pain management
in young people is important, because acute pain or exposure
to intense pain and stress can be risk factors that contribute
to transitions from acute to chronic pain [41]. Our results
show that only about 20% of our sample had incomes that
were less than or equal to € 36,000 a year. Although low
incomes are described as being risk factors for chronic pain
[42, 43], we cannot discuss this result because the National
Health System in Italy guarantees and safeguards minority
patients and those living in poverty and reduces disparities in
health. Moreover, about 50% of the patients in our study had
pain that had lasted for up to or more than 48 months and about
25% of the sample have multisite localizations. These pain
characteristics may have negative impacts on the quality of
life of the patients [4] and may also lead to important negative
socioeconomic and pharmacoeconomic impacts. The main
social costs associated with pain are related to loss of pro-
ductivity, use of health care [44], absenteeism, presenteeism
[45] and comorbidity such as depressive symptoms. Our
data demonstrate that musculoskeletal pain is more common
than mixed and neuropathic pain, as described by two other
Italian studies [19, 26]. The different settings could explain
this high rate because patients referring to GPs probably have
less complex pain than those who seek pain clinics. The
most common sites for pain were osteoarthritis, unspecified or
localized pain, sciatica and low back pain, and these results are
similar to those found by other studies [46]. The reason for the
very low number of patients with visceral pain may be that, in
Italy, these patients are usually referred to specialized doctors
or pain clinics rather than to GPs. In our study, neuropathic
pain was associated with patients who were over 70 years of
age, those who had one or more sites of pain and those who
used adjuvants, such as antidepressants and anticonvulsants,
up to six times more than patients affected by musculoskeletal
pain. However, our data shows that patients who were under
70 years of age were less likely to suffer from neuropathic
pain. These results are described in other studies conducted
on PMCs [19]. Furthermore, in accordance with other studies,
ours showed that NSAIDs which means that the intensity of
the pain is low-mild. Moreover, NSAIDs were used more
59
TABLE 3. Classification and clinical diagnoses of chronic pain according to ICD-9.
Classification and Clinical Diagnosis of Chronic Pain* Male (N = 360) Female (N = 1,040) Total (N = 1,400)
n % n % n %
Chronic Musculoskeletal Pain (MSK)
Osteoarthrosis, unspecified generalized or localized 86 23.9 262 25.2 348 24.9
Sciatica/low back pain 63 17.5 153 14.7 216 15.4
Displacement of intervertebral disc, site unspecified 50 13.9 118 11.3 168 12.0
Spondylosis of unspecified site 23 6.4 88 8.5 111 7.9
Pain in joint, leg 23 6.4 82 7.9 105 7.5
Arthralgia, unspecified 16 4.4 73 7.0 89 6.4
Arthritis, unspecified generalized or localized 15 4.2 67 6.4 82 5.9
Cervicalgia 20 5.6 39 3.8 59 4.2
Fracture lower limb 6 1.7 22 2.1 28 2.0
Joint pain, arms 7 1.9 15 1.4 22 1.6
Pain in joint, shoulder region 10 2.8 10 1.0 20 1.4
Injuries spine, unspecified site 1 0.3 15 1.4 16 1.1
Chest pain 5 1.4 9 0.9 14 1.0
Fracture upper limb 4 1.1 9 0.9 13 0.9
Rheumatoid arthritis 3 0.8 8 0.8 11 0.8
Muscle disorders 3 0.8 7 0.7 10 0.7
Spinal stenosis, unspecified region 1 0.3 4 0.4 5 0,4
Head trauma 1 0.3 1 0.1 2 0.1
Chronic Neuropathic Pain (NP)
Herpes zoster, dermatitis of eyelid or unspecified 4 1.1 16 1.5 20 1.4
Polyneuropathy of various etiology 9 2.5 7 0.7 16 1.1
Trigeminal neuralgia and other sites 6 1.7 9 0.9 15 1.1
Idiopathic peripheral neuropathy 4 1.1 7 0.7 11 0.8
Myalgia and myositis, unspecified (fibromyalgia) 0 0 5 0.5 5 0.4
Chronic visceral pain and Other origin
Colic, epigastricpain, dysmenorrhea 0 0 8 0.8 8 0.6
Undefined Chronic Pain
Les, scleroderma, Sjogren syndrome* 0 0 6 0.6 6 0.4
ICD-9: International Classification of Diseases, Ninth Revision; NOS: not otherwise specified.
* Percentages do not add up to 100% because categories are not mutually exclusive.
frequently than opioids, and confirmed the very limited use of
adjuvants and acetaminophen [4, 26, 47]. Although the Italian
Medicines Agency (AIFA) reports an increase in the use of
opioids for the treatment of pain over the last seven years, GPs
prefer to prescribe NSAIDs than opioids. The draft guideline
recommends that some antidepressants can be considered for
people with chronic primary pain. However, they say that ben-
zodiazepines, acetaminophen, NSAIDs and opioids should not
be offered because there is little or no evidence that they make
any difference to people’s quality of life, and there is evidence
that they can cause harm, including possible addiction [48].
For their maximum effective or tolerated doses, assessments
need to be made of the levels of analgesia produced, and
the drugs that did not produce the desired therapeutic effects
should be withdrawn. As patients’ requirements for analgesia
will change over time, periodic and ongoing drug reviews are
needed to ensure that the drugs continue to be appropriate, the
analgesia is achieving the best possible clinical outcomes and
the patients are not experiencing side effects.
4.1 Limitations
Although this study offers data about the management of
chronic pain in primary care in Italy, it has several limitations.
First, a considerable amount of socio-demographic data and
intensity of pain are often missing in the databases of the GPs
and secondly, these results represent only part of one region
in Italy. Also, primary care does not provide an interdisci-
plinary approach through multidimensional assessments of the
patients. Finally, we used a small sample because we included
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TABLE 4. Univariate and multivariate logistic regression model results.
Variables Univariate Multivariatea)
OR 95% CI P-value OR 95% CI P-value
Sex
Male 1
Female 0.78 0.57-1.07 0.118
Age (years)
< 70 1 1
≥ 70 0.66 0.50-0.88 0.004 0.62 0.45-0.85 0.003
N° of sites with pain
0 1
1 2.62 1.55-4.43 < 0.001 2.59 1.49-4.51 0.001
2 5.58 3.20-9.75 < 0.001 6.14 3.40-11.11 < 0.001
3+ 6.06 2.60-14.12 < 0.001 5.68 2.30-14.06 < 0.001
Duration of pain (months)
< 48 1
≥ 48 1.10 0.83-1.46 0.491
Fans +/- Opioid use
No 1
Yes 0.27 0.16-0.47 < 0.001
Antidepressive +/- Anticonvulsants use
No 1 1
Yes 6.25 4.42-8.84 < 0.001 6.82 4.74-9.81 < 0.001
a)Forward selection; OR = odds ratio; 95% CI = 95% Confidence Interval.
only patients who had been affected by chronic pain for six
months or more, so we could understand the sample in this
study.
5. Conclusions
Chronic pain requires personalized management according to
a bio-psycho-social model. It is useful for GPs and their
patients to discuss and agree on treatment goals before ini-
tiating treatment, to have objective standards against which
to assess treatment success or failure. An overall reduction
of pain intensity is the first outcome, but patients need to
improve the quality of their lives, which GPs alone cannot
guarantee. The measurement of pain intensity is not often
documented in primary care, and the high number of patients
taking anti-inflammatories, which probably means that the
intensity of the pain is low-mild. It is important to consolidate
one interdisciplinary approach through other disciplines such
as Nursing and Psychology to maximize the results in terms
of quality of life, adherence and costs [49, 50]. Moreover,
an optimal transitional process from GPs to PMCs should be
tested to prevent the needless suffering of those with chronic
pain.
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